GeneDx Holdings Corp’s latest rating changes from various analysts

In a filing, GeneDx Holdings Corp revealed its CHIEF EXECUTIVE OFFICER Stueland Katherine unloaded Company’s shares for reported $90661.0 on Mar 18 ’24. In the deal valued at $10.59 per share,8,559 shares were sold. As a result of this transaction, Stueland Katherine now holds 66,698 shares worth roughly $0.8 million. Then, Feeley Kevin sold 3,253 […]